Blue Rubicon set for Panadol brief
Panadol, the GlaxoSmithKline-owned painkiller brand, is to be promoted by Blue Rubicon.
The agency is to handle UK trade and consumer campaigns on a brief that focuses on differentiating between types of pain. It will highlight what Panadol is best used for.
Agency partner Chris Jones heads a comms team of four, reporting to GSK group brand manager Lucy Chown.
Blue Rubicon already works with GSK on consumer campaigns for Ribena, as well as handling media training for staff.
It also advises on crisis management for GSK's consumer health arm.
Have your say
Only registered users may comment. Please login to comment.
LOGIN TO PRWEEK
Existing users log in here
Subscriptions
Not a subscriber? View PR Week subscription options here.
Already a paid subscriber?
If you have a paid subscription to PRWeek magazine but have not used PRWeek.com before, please click here to activate your subscription.
Jobs
TOP JOB
Account Executive - b2b Media/Tech
£Competitive
FEATURED JOBS
Senior Internal Communications Practitioner
65k - £90k + excellent bonus
In-house - Housing - Press & PR Officer
£26,500 - £32,500
Email Bulletins
Sign up here to receive daily e-mail bulletins covering the latest PR developments from the UK and across the globe.






